+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "High Content Screening"

From
From
From
Cell-Based Assays Market Report 2024-2034 - Product Thumbnail Image

Cell-Based Assays Market Report 2024-2034

  • Report
  • January 2024
  • 314 Pages
  • Global
From
3D Cell Cultures: Technologies and Global Markets - Product Thumbnail Image

3D Cell Cultures: Technologies and Global Markets

  • Report
  • February 2024
  • 442 Pages
  • Global
From
ADME-Toxicology Testing - Global Strategic Business Report - Product Thumbnail Image

ADME-Toxicology Testing - Global Strategic Business Report

  • Report
  • May 2024
  • 472 Pages
  • Global
From
From
Loading Indicator

High Content Screening (HCS) is a biotechnology technique used to analyze and quantify the effects of drugs, chemicals, and genetic modifications on cells. It is a powerful tool for drug discovery and development, as well as for basic research. HCS combines automated microscopy, image analysis, and data management to provide a comprehensive view of cellular responses. It can be used to measure a variety of cellular parameters, including cell morphology, protein expression, and gene expression. HCS is used in a variety of applications, including drug discovery, toxicity testing, and stem cell research. It is also used to study the effects of environmental factors on cells, such as temperature, pH, and light. HCS is becoming increasingly important in the biotechnology industry, as it allows researchers to quickly and accurately analyze large amounts of data. Some companies in the HCS market include Thermo Fisher Scientific, PerkinElmer, GE Healthcare, BioTek Instruments, and Olympus. Show Less Read more